Tissue Glue

First-In-Class Wound Closure Target Product

N8 Medical is pursuing wound closure devices with ceragenins incorporated that leverage their anti-inflammatory and would healing properties.

  • Wound closure is a $2 billion+ category growing at an annual growth rate of 2-3%
  • Market for wound closure adhesives is currently greater than $200 million
  • A tissue adhesive with ceragenin-incorporated is being developed to:*
    • Reduce bacterial burden after closure
    • Reduce inflammation and accelerate wound closure
    • Reduce scarring and improve cosmesis
  • Same technology can be utilized for microbial sealants
*CAUTION: IN THE UNITED STATES, THE REFERENCED PRODUCT HAS NOT BEEN GRANTED MARKETING APPROVAL BY FDA, AND IS NOT AVAILABLE FOR COMMERCIAL SALE. THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION.